CLIA Interpretive Guidelines:

Appendix C of the State Operations Manual

January 2004

Sharon G. Ehrmeyer, Ph.D. and James O. Westgard, Ph.D. NACB

Most of us have questions about the meaning and interpretation of the CLIA rules and regulations. To address these issues, CMS has published “interpretive guidelines” that are available on the Internet [1, www.cms.gov/clia/appendc.asp]. Given that these guidelines were just published on January 12, 2004, many of us also have questions about the meaning and interpretation of the new interpretative guidelines.

The interpretive guidelines are technically identified as Appendix C of the State Operations Manual (SOM, CMS Publication 7), a manual used by states in administering various federal programs, not just CLIA. However, these updated Interpretive Guidelines have a new twist in that they have become a companion to the final CLIA Rule [2]. In the past, surveyors primarily used the probes listed in the Guidelines during the inspection process to determine a laboratory’s compliance with a particular standard. Now the document is being made available to laboratories to help them better understand the CLIA requirements and also to provide additional regulatory information not included in the Final Rule. For example, section §493.1256(d), Standard Control procedures, states: “Unless CMS approves a procedure, specified in Appendix C of the State Operations Manual, that provides ‘equivalent quality testing,’ the laboratory must…” follow the rules found in §493.1256 of the Federal Register [page 3707-8, reference 2]. The information on “equivalent quality testing” is found only in the SOM.

Organization

Appendix C includes 7 sections that are available as Portable Document Files (PDF) that can be downloaded to your computer or printed directly. The PDF format requires that you have the Adobe Acrobat Reader installed on your computer (which is available free and can be downloaded from the Adobe website www.adobe.com/products/acrobat/readstep2.html.)

  1. Policy for conducting surveys (270K PDF, 18 pages)
  2. Index and Subparts A-H. General Provisions, Certificates and Proficiency Testing: §493.1100 – §493.865 (925K PDF, 59 pages)
  3. Subpart J. Facility Administration: §493.1100 – §493.1105 (211K PDF, 11 pages)
  4. Subpart K, Part 1. Quality System for Nonwaived Testing; General Laboratory systems, Preanalytic Systems & Analytic Systems - general requirements: §493.1200 – §493.1256 (770K PDF, 59 pages)
  5. Subpart K, Part 2. Quality System for Nonwaived Testing; Analytic Systems – specialty and subspecialty requirements – and Postanalytic Systems: 493.1261 – 493.1495 (1.2MB PDF, 77 pages)
  6. Subpart M. Personnel: §493.1351 – §493.1495 (585K PDF, 61 pages)
  7. Subpart Q. Inspection: §493.1771 – §493.1780 (137K PDF, 11 pages)

That’s a total of 296 pages of new materials to help you better understand the CLIA Final Rule and how it will be applied in laboratory inspections.

Format and content

Unlike the previous Appendix C that was organized in table format, the new version follows the format:

Deficiency “D-tag number”
    CLIA standard
       Interpretive Guidelines, and
        Probes

Here’s an example for §493.1251(a) Standard: Procedure Manual.

“D5401
§493.1251 Standard: Procedure Manual

(a) A written procedures manual for all tests, assays, and examinations performed by the laboratory must be available to, and followed by, laboratory personnel. Textbooks may supplement but not replace the laboratory’s written procedures for testing or examining specimens.

Interpretive Guidelines §493.1251(a):

Procedures may be organized in the form of manuals, stored in computers and/or card files. Use D5401, if the procedure manual lacks any of the applicable information as specified in §493.1251(b)(1)-(14). If the laboratory has procedures that are not used for test performance, but are used for reference purposes, they may be placed in a reference section. You need not review reference procedures unless problems are identified with patient test results.

Centers for Disease Control and Prevention (CDC) and Armed Forces Institute of Pathology (AFIP) manuals, manufacturer’s operating instructions, and package inserts, are acceptable provided the policies and procedures are available, and the methods in use are clearly indicated. If the laboratory modifies any procedure, the modification must be documented and verified/established as specified in §493.1253.

Probes §493.1251(a):

How does the laboratory ensure that personnel follow the procedures in the procedure manual? How are changes in procedures communicated to laboratory personnel? For competency issues, use D6030 or D6103 as applicable.”

All CLIA standards have a “D-tag” assigned. When a laboratory is found in noncompliance with a particular standard, the surveyor cites the associated “D” number rather that the specific standard.

The Interpretive Guidelines section is designed to provide more information to both the laboratory and surveyor on how to meet the particular requirement. For the procedure manual example, the surveyor also is informed to use a specific D-tag “D5410” when the test site omits required information and to review the laboratory’s reference procedures only when problems occur with patient test results.

The Probes section is included to assist the surveyor in determining whether the laboratory is in compliance with the standard. These probes are in the form of questions and, for the procedure manual example, the surveyor is told to investigate how the laboratory ensures personnel follow the procedures and also to identify what mechanism is used to inform testing personnel of changes in the manual. Obviously, it is useful for the laboratory to be familiar with the probes since the surveyor should be following these directions during the inspection.

While there will be a D-tag for each CLIA standard listed, not all standards are included in the Interpretive Guidelines and/or Probes sections.

Issues and Answers

How should you use these Guidelines if inspected by CMS?

If your laboratory is inspected for CLIA compliance, be very familiar with the Guidelines and use them as a companion document to the Final Rule.

What if your laboratory is inspected by a professional accrediting organization?
CMS “deems” or approves certain professional accrediting organizations, such as the College of American Pathologists (CAP), the Joint Commission for Accreditation of Healthcare Organizations (JCAHO), and the Commission for Office Laboratory Accreditation (now called COLA), as having requirements as or more stringent than CLIA and therefore allows them to carry out laboratory inspections [3].

Inspections conducted by these government-approved accrediting organizations are based on the specific testing requirements of the particular organization. By meeting the accrediting organizations requirements, test sites, in essence, also are meeting the CLIA requirements.

In most cases each of these organizations’ issues their own test standards and provides information similar to what appears in the Interpretive Guidelines section of Appendix C, for example:

CAP’s Laboratory General Checklist item GEN.11742 asks [4]: “Is there evidence that problems identified by proficiency testing and alternative performance assessment have been recognized and corrected?”

JCAHO’s standard QC.1.110 states [5]: “The laboratory ensures that quality control results meet its criteria for acceptability before it reports patient test results.” The ELEMENTS OF PERFORMANCE section for this standard provides insight into what the inspector will want to see: (1) For each area of the laboratory, defined criteria exist for evaluating the acceptability of control and calibration results. (2) Individual results are not reported unless these criteria are met.

Don’t the interpretative guidelines allow CLIA to change the rules published in the Federal Register?

That certainly appears to be the case. As we have discussed earlier on this website, the interpretative guidelines for “equivalent” QC procedures [6] deviate greatly from the requirements for appropriate QC procedures [7] stated in the Federal Register. The advantage of using the SOM to make these changes is that CMS minimizes the need to solicit public comments and, likewise, minimizes the need to defend these changes. In effect, the SOM gives CMS considerable flexibility in the way the CLIA rules are actually applied and enforced.

DO’s and DON’Ts

References

  1. Appendix C of SOM, Regulations and Interpretive Guidelines for Laboratories and Laboratory Services, http://www.cms.gov/clia/appendc.asp
  2. CLIA Final Rule (2002 codification of all previous rules (1992-2002). http://www.phppo.cdc.gov/clia/pdf/42cfr49302.pdf and CLIA Final Rule (January 24, 2003) http://www.phppo.cdc.gov/clia/pdf/CMS-2226-F.pdf
  3. Listing of government-approved accrediting organizations. http://www.cms.gov/clia/accrdorg.asp
  4. CAP Laboratory Accreditation Checklists. http://www.cap.org/apps/docs/laboratory_accreditation/checklists/checklistftp.html
  5. JCAHO standards. Joint Commission on Accreditation of Healthcare Organizations, One Renaissance Blvd., Oakbrook Terrace, IL 60181
  6. Westgard JO. CLIA Final Rule: Equivalent Quality Control Practices. www.westgard.com/cliafinalrule7.htm
  7. Westgard JO. CLIA Final Rule: Appropriate QC Procedures. www.westgard.com/cliafinalrule9.htm

See the Entire CLIA Final Rule Series: